CompareMarketResearchRequest a sample
Home / Healthcare / Biopharmaceutical Logistics

Healthcare · Market report

Biopharmaceutical Logistics Market Size, Share and Forecast 2026-2036

The global biopharmaceutical logistics market is worth USD 21.7 bn in 2026 and is forecast to reach USD 51.4 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Refrigerated 2 to 8 C is the largest by temperature segment.

USD 21.7 bnMarket size 2026
USD 51.4 bnForecast 2036
9.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global biopharmaceutical logistics market is worth USD 21.7 bn in 2026 and is forecast to reach USD 51.4 bn by 2036, growing at a 9.0% CAGR. United States is the largest country market and Refrigerated 2 to 8 C is the largest by temperature segment.

ScopeBiopharmaceutical logistics: temperature-controlled transport, storage, packaging and clinical-supply handling of biologics, vaccines, cell and gene therapies and trial materials.
IndustryHealthcare
Value 2025USD 20.0 bn
Value 2026USD 21.7 bn
Value 2036USD 51.4 bn
CAGR 2026-20369.0%
Volume 202642.8 million shipments
Volume 203687.2 million shipments
Average price 2026USD 508 per shipment
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Biopharmaceutical Logistics market size and forecast, 2026-2036

Exhibit 1The global biopharmaceutical logistics market is forecast to grow from USD 21.7 bn in 2026 to USD 51.4 bn by 2036, more than doublingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 9.0%
Biopharmaceutical Logistics market value, 2025 to 2036Market value by year. 2025: USD 20.0 bn; 2026: USD 21.7 bn; 2027: USD 23.7 bn; 2028: USD 25.8 bn; 2029: USD 28.1 bn; 2030: USD 30.6 bn; 2031: USD 33.4 bn; 2032: USD 36.4 bn; 2033: USD 39.7 bn; 2034: USD 43.2 bn; 2035: USD 47.1 bn; 2036: USD 51.4 bn. Compound annual growth rate 2026 to 2036: 9.0%.202521.7 bn202633.4 bn203151.4 bn20369.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 21.7 bn
2027USD 23.7 bn
2028USD 25.8 bn
2029USD 28.1 bn
2030USD 30.6 bn
2031USD 33.4 bn
2032USD 36.4 bn
2033USD 39.7 bn
2034USD 43.2 bn
2035USD 47.1 bn
2036USD 51.4 bn

Biopharmaceutical Logistics market segmentation

By temperature

Exhibit 2Refrigerated 2 to 8 C is the largest segment by temperature, with 58.0% of 2026 revenueEstimated share of 2026 global revenue, by temperature
Biopharmaceutical Logistics market share by temperature, 2026Share of 2026 revenue by temperature. Refrigerated 2 to 8 C: 58.0%; Frozen and ultra-cold: 18.0%; Controlled ambient: 16.0%; Cryogenic: 8.0%.Refrigerated 2 to 8 C58.0%Frozen and ultra-cold18.0%Controlled ambient16.0%Cryogenic8.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Refrigerated 2 to 8 C58.0%52.8%USD 12.6 bn8.0%
Frozen and ultra-cold18.0%22.6%USD 3.9 bn11.5%
Cryogenic8.0%12.5%USD 1.7 bn14.0%
Controlled ambient16.0%12.1%USD 3.5 bn6.0%

By service

Exhibit 3Transportation adds the most revenue by service, growing from USD 11.3 bn in 2026 to USD 25.0 bn by 2036Estimated revenue in USD by service, 2026 and 2036 forecast
Biopharmaceutical Logistics market by service, 2026 and 2036Revenue by service in 2026 and 2036. Transportation: USD 11.3 bn in 2026, USD 25.0 bn in 2036, change +121%; Warehousing and storage: USD 5.2 bn in 2026, USD 12.6 bn in 2036, change +143%; Packaging and cold-chain equipment: USD 3.0 bn in 2026, USD 7.7 bn in 2036, change +154%; Clinical trial logistics: USD 2.2 bn in 2026, USD 6.0 bn in 2036, change +178%.20262036 forecastChangeTransportation+121%11.3 bn25.0 bnWarehousing and storage+143%5.2 bn12.6 bnPackaging and cold-chain equipment+154%3.0 bn7.7 bnClinical trial logistics+178%2.2 bn6.0 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Transportation52.0%48.6%USD 11.3 bn8.3%
Warehousing and storage24.0%24.6%USD 5.2 bn9.3%
Packaging and cold-chain equipment14.0%15.0%USD 3.0 bn9.8%
Clinical trial logistics10.0%11.8%USD 2.2 bn10.8%

By product

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Biologics and biosimilars44.0%43.8%USD 9.5 bn8.9%
Vaccines20.0%15.1%USD 4.3 bn6.0%
Cell and gene therapies10.0%17.7%USD 2.2 bn15.4%
Clinical trial materials14.0%13.9%USD 3.0 bn8.9%
Other12.0%9.5%USD 2.6 bn6.5%

By mode

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Air42.0%40.0%USD 9.1 bn8.5%
Road30.0%30.0%USD 6.5 bn9.0%
Ocean10.0%10.0%USD 2.2 bn9.0%
Rail and intermodal18.0%20.0%USD 3.9 bn10.2%

By packaging

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Active temperature controlled34.0%36.0%USD 7.4 bn9.6%
Passive insulated46.0%42.0%USD 10.0 bn8.0%
Reusable containers20.0%22.0%USD 4.3 bn10.0%

Top 25 countries for biopharmaceutical logistics by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 81.5% of 2026 revenue and the 25 countries below together hold 95.9%.

Exhibit 4United States is the largest country market at USD 8.0 bn in 2026, and the three largest countries hold 53.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Biopharmaceutical Logistics market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 8.0 bn, 37.0%; Germany: USD 1.7 bn, 8.0%; China: USD 1.7 bn, 8.0%; United Kingdom: USD 1.1 bn, 5.0%; France: USD 1.1 bn, 5.0%; Japan: USD 1.1 bn, 5.0%; Switzerland: USD 868 mn, 4.0%; Netherlands: USD 760 mn, 3.5%; India: USD 651 mn, 3.0%; Canada: USD 651 mn, 3.0%.United States8.0 bn 37.0%Germany1.7 bn 8.0%China1.7 bn 8.0%United Kingdom1.1 bn 5.0%France1.1 bn 5.0%Japan1.1 bn 5.0%Switzerland868 mn 4.0%Netherlands760 mn 3.5%India651 mn 3.0%Canada651 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 8.0 bn37.0%USD 18.6 bn8.8%
2GermanyUSD 1.7 bn8.0%USD 3.9 bn8.3%
3ChinaUSD 1.7 bn8.0%USD 5.1 bn11.3%
4United KingdomUSD 1.1 bn5.0%USD 2.4 bn8.3%
5FranceUSD 1.1 bn5.0%USD 2.3 bn7.9%
6JapanUSD 1.1 bn5.0%USD 2.1 bn6.9%
7SwitzerlandUSD 868 mn4.0%USD 2.0 bn8.7%
8NetherlandsUSD 760 mn3.5%USD 1.7 bn8.7%
9IndiaUSD 651 mn3.0%USD 2.0 bn11.9%
10CanadaUSD 651 mn3.0%USD 1.5 bn8.6%
11BelgiumUSD 482 mn2.2%USD 1.1 bn9.0%
12SingaporeUSD 386 mn1.8%USD 1.0 bn10.3%
13IrelandUSD 380 mn1.8%USD 899 mn9.0%
14SpainUSD 306 mn1.4%USD 724 mn9.0%
15South KoreaUSD 245 mn1.1%USD 652 mn10.3%
16ItalyUSD 241 mn1.1%USD 570 mn9.0%
17AustraliaUSD 228 mn1.1%USD 539 mn9.0%
18SwedenUSD 167 mn0.8%USD 396 mn9.0%
19DenmarkUSD 156 mn0.7%USD 370 mn9.0%
20BrazilUSD 124 mn0.6%USD 329 mn10.3%
21TaiwanUSD 115 mn0.5%USD 308 mn10.4%
22PolandUSD 106 mn0.5%USD 283 mn10.3%
23IsraelUSD 78 mn0.4%USD 185 mn9.0%
24MexicoUSD 63 mn0.3%USD 164 mn10.1%
25AustriaUSD 54 mn0.2%USD 128 mn9.0%
Rest of worldUSD 883 mn4.1%USD 2.0 bn8.5%
Exhibit 5United States and China account for 47% of the USD 29.7 bn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Biopharmaceutical Logistics market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 21.7 bn. United States: +USD 10.6 bn; China: +USD 3.3 bn; Germany: +USD 2.1 bn; India: +USD 1.4 bn; United Kingdom: +USD 1.3 bn; 20 other countries: +USD 9.8 bn; Rest of world: +USD 1.1 bn. Market value 2036: USD 51.4 bn.Market value 202621.7 bnUnited States+10.6 bnChina+3.3 bnGermany+2.1 bnIndia+1.4 bnUnited Kingdom+1.3 bn20 other countries+9.8 bnRest of world+1.1 bnMarket value 203651.4 bn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • UPS
  • DHL Group
  • FedEx
  • Kuehne+Nagel
  • World Courier
  • DSV
  • DB Schenker

Group 2: Regional and specialist players

  • Cencora
  • Cryoport
  • Envirotainer
  • Sonoco ThermoSafe
  • va-Q-tec
  • CSafe Global
  • Lufthansa Cargo

Group 3: Emerging and niche players

  • Biocair
  • Yourway
  • QuickSTAT

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the biopharmaceutical logistics market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 9.0% is calculated from the resulting values.

The market is divided by temperature, by service, by product, by mode, by packaging. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the biopharmaceutical logistics market?

The global biopharmaceutical logistics market is estimated at USD 20.0 bn in 2025 and USD 21.7 bn in 2026.

How fast will the biopharmaceutical logistics market grow?

It is forecast to reach USD 51.4 bn by 2036, a compound annual growth rate of 9.0% from 2026, an increase of USD 29.7 bn.

Which country is the largest market for biopharmaceutical logistics?

United States is the largest market by revenue at USD 8.0 bn in 2026, 37.0% of the global total. The three largest countries together hold 53.0%.

Which country is growing fastest?

Among the ten largest markets, India is growing fastest at 11.9% a year from 2026 to 2036.

Which biopharmaceutical logistics segment is largest?

In the by temperature split, Refrigerated 2 to 8 C is the largest segment with 58.0% of 2026 revenue.

Who are the leading biopharmaceutical logistics companies?

Global leaders include UPS, DHL Group, FedEx, Kuehne+Nagel.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Biomarker Discovery Bioreactor →

All Healthcare markets →

Request a sample